Retrospective study on the impact of penile corpus cavernosum injection test on penile vascular function

  • Yan CHEN ,
  • Kuangmeng LI ,
  • Kai HONG ,
  • Shudong ZHANG ,
  • Jianxing CHENG ,
  • Zhongjie ZHENG ,
  • Wenhao TANG ,
  • Lianming ZHAO ,
  • Haitao ZHANG ,
  • Hui JIANG ,
  • Haocheng LIN
Expand
  • 1. Department of Urology, Peking University Third Hospital, Beijing 100191, China
    2. Reproductive Medicine Center, Peking University Third Hospital, Beijing 100191, China
    3. Department of Ultrasound, Peking University Third Hospital, Beijing 100191, China
    4. Department of Urology, Peking University First Hospital, Beijing 100034, China

Received date: 2024-03-16

  Online published: 2024-07-23

Supported by

the National Natural Science Foundation of China(82371633);the Fundamental Research Funds for the Central Universities: Peking University Clinical Scientist Program(BMU2023PYJ H012)

Abstract

Objective: To investigate the impact of age, various hormonal levels, and biochemical markers on penile cavernous body vascular function in patients with erectile dysfunction (ED). Me-thods: A retrospective analysis of clinical data from male patients with ED who underwent color duplex Doppler ultrasonography (CDDU) and intracavernosal injection test (ICI) at the Reproductive Medicine Center of Peking University Third Hospital from January 2020 to August 2023. Data were managed and processed using SPSS 29.0, and a multivariable Logistic regression analysis was conducted. Results: A total of 700 ED patients were included, with 380 showing negative ICI results and 320 positive. In the study, 84 patients had a peak systolic velocity (PSV) < 25 cm/s, while 616 had PSV≥25 cm/s; 202 patients had end-diastolic velocity (EDV)>5 cm/s, and 498 had EDV≤5 cm/s. 264 patients had abnormal PSV and/or EDV results, and 436 had normal results for both. Patients with vascular ED had significantly lower estrogen levels (t=-3.546, P < 0.001), lower testosterone levels (t=-2.089, P=0.037), and a higher rate of hyperglycemia (χ2=12.772, P=0.002) compared with those with non-vascular ED. The patients with arterial ED were older (t=3.953, P < 0.001), had a higher rate of hyperglycemia (χ2=9.518, P=0.009), and a higher estrogen/testosterone ratio (t=2.330, P=0.020) compared with those with non-arterial ED. The patients with mixed arteriovenous ED had higher age (t=3.567, P < 0.001), lower testosterone levels (t=-2.288, P=0.022), a higher rate of hyperglycemia (χ2=12.877, P=0.002), and a larger estrogen/testosterone ratio (t=2.096, P=0.037) compared with those with normal findings. Multifactorial Logistic regression analysis indicated that higher levels of estrogen were a protective factor for vascular ED (OR=1.009, 95%CI: 1.004-1.014), and glucose≥7.0 mmol/L was a risk factor (OR=0.381, 95%CI: 0.219-0.661). Older age was a risk factor for arterial ED (OR=0.960, 95%CI: 0.938-0.982). Additionally, older age (OR=0.976, 95%CI: 0.958-0.993) and glucose levels of 5.6-6.9 mmol/L (OR=0.591, 95%CI: 0.399-0.876) were also risk factors for mixed arterio-venous ED. Conclusion: Hyperglycemia and aging may impair penile cavernous body vascular function, while higher levels of estrogen may have a protective effect on it.

Cite this article

Yan CHEN , Kuangmeng LI , Kai HONG , Shudong ZHANG , Jianxing CHENG , Zhongjie ZHENG , Wenhao TANG , Lianming ZHAO , Haitao ZHANG , Hui JIANG , Haocheng LIN . Retrospective study on the impact of penile corpus cavernosum injection test on penile vascular function[J]. Journal of Peking University(Health Sciences), 2024 , 56(4) : 680 -686 . DOI: 10.19723/j.issn.1671-167X.2024.04.022

References

1 Liu K , Sun T , Luan Y , et al. Berberine ameliorates erectile dysfunction in rats with streptozotocin-induced diabetes mellitus through the attenuation of apoptosis by inhibiting the SPHK1/S1P/S1PR2 and MAPK pathways[J]. Andrology, 2022, 10 (2): 404- 418.
2 Ayta IA , Mckinlay JB , Krane RJ . The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences[J]. BJU Int, 1999, 84 (1): 50- 56.
3 Feldman HA , Goldstein I , Hatzichristou DG , et al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts male aging study[J]. J Urol, 1994, 151 (1): 54- 61.
4 金淼, 颜建飞, 齐信王, 等. 彩色多普勒超声结合阴茎勃起硬度分级对勃起功能障碍的诊断价值研究[J]. 中国性科学, 2023, 32 (8): 5- 8.
5 Yuan C , Jian Z , Gao X , et al. Type 2 diabetes mellitus increases risk of erectile dysfunction independent of obesity and dyslipidemia: A Mendelian randomization study[J]. Andrology, 2022, 10 (3): 518- 524.
6 Leroy TJ , Broderick GA . Doppler blood flow analysis of erectile function: Who, when, and how[J]. Urol Clin North Am, 2011, 38 (2): 147- 154.
7 蓝晓锋, 姜凡, 彭梅, 等. SMI技术对血管性阴茎勃起功能障碍的诊断价值[J]. 中国超声医学杂志, 2018, 34 (11): 1028- 1031.
8 范叶柏, 陈翔, 金拓, 等. 阴茎海绵体注射在勃起功能障碍诊治中的应用[J]. 中国男科学杂志, 2016, 30 (10): 70- 72.
9 张羽, 湛永健, 湛炜璋, 等. 阴茎海绵体彩色双功能多普勒超声检查在血管性阴茎勃起功能障碍诊断中的应用[J]. 微创医学, 2015, 10 (3): 293- 295.
10 Sasayama S , Ishii N , Ishikura F , et al. Men's health study: Epidemiology of erectile dysfunction and cardiovascular disease[J]. Circ J, 2003, 67 (8): 656- 659.
11 Grover SA , Lowensteyn I , Kaouache M , et al. The prevalence of erectile dysfunction in the primary care setting: Importance of risk factors for diabetes and vascular disease[J]. Arch Intern Med, 2006, 166 (2): 213- 219.
12 Manolis A , Doumas M . Sexual dysfunction: The 'prima ballerina' of hypertension-related quality-of-life complications[J]. J Hypertens, 2008, 26 (11): 2074- 2084.
13 Selvin E , Burnett AL , Platz EA . Prevalence and risk factors for erectile dysfunction in the US[J]. Am J Med, 2007, 120 (2): 151- 157.
14 2023年ADA糖尿病最新诊断标准(187)[J]. 临床心电学杂志, 2023, 32(6): 466.
15 Boerl L , Capogrosso P , Ventimiglia E , et al. Sexual dysfunction in men with prediabetes[J]. Sex Med Rev, 2020, 8 (4): 622- 634.
16 Ponholzer A , Temml C , Mock K , et al. Prevalence and risk factors for erectile dysfunction in 2 869 men using a validated questionnaire[J]. Eur Urol, 2005, 47 (1): 80- 85.
17 Fontaine C , Morfoisse F , Tatin F , et al. The impact of estrogen receptor in arterial and lymphatic vascular diseases[J]. Int J Mol Sci, 2020, 21 (9): 3244.
18 Yafi FA , Jenkins L , Albersen M , et al. Erectile dysfunction[J]. Nat Rev Dis Primers, 2016, 2, 16003.
19 Burnett AL . Novel nitric oxide signaling mechanisms regulate the erectile response[J]. Int J Impot Res, 2004, 16 (Suppl 1): S15- S19.
20 Seeland U , Demuth I , Regitz-zagrosek V , et al. Sex differences in arterial wave reflection and the role of exogenous and endogenous sex hormones: Results of the Berlin Aging Study Ⅱ[J]. J Hypertens, 2020, 38 (6): 1040- 1046.
21 刘文华, 张治芬, 汤珊珊, 等. 17β-雌二醇下调MCP-1及RhoA表达发挥心血管保护作用[J]. 国际生殖健康/计划生育杂志, 2017, 36 (5): 373- 377.
22 Gayard M , Guilluy C , Rousselle A , et al. AMPK alpha 1-induced RhoA phosphorylation mediates vasoprotective effect of estradiol[J]. Arterioscler Thromb Vasc Biol, 2011, 31 (11): 2634- 2642.
23 马洁桦. 阴茎海绵体雌激素受体β在勃起功能障碍发病中的作用及机制研究[D]. 南京: 南京师范大学, 2012.
24 Irwin GM . Erectile dysfunction[J]. Prim Care, 2019, 46 (2): 249- 255.
25 Pathak RA , Broderick GA . Color Doppler duplex ultrasound parameters in men without organic erectile dysfunction[J]. Urology, 2020, 135, 66- 70.
Outlines

/